Merke DP - Search Results

1

A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia.

Laue L, Merke DP, Jones JV, Barnes KM, Hill S, Cutler GB Jr. Laue L, et al. Among authors: merke dp. J Clin Endocrinol Metab. 1996 Oct;81(10):3535-9. doi: 10.1210/jcem.81.10.8855797. J Clin Endocrinol Metab. 1996. PMID: 8855797 Clinical Trial.

2

Evaluation and management of precocious puberty.

Merke DP, Cutler GB Jr. Merke DP, et al. Arch Dis Child. 1996 Oct;75(4):269-71. doi: 10.1136/adc.75.4.269. Arch Dis Child. 1996. PMID: 8984908 Free PMC article. Review. No abstract available.

3

New approaches to the treatment of congenital adrenal hyperplasia.

Merke DP, Cutler GB Jr. Merke DP, et al. JAMA. 1997 Apr 2;277(13):1073-6. JAMA. 1997. PMID: 9091697 No abstract available.

4

Novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11 beta-hydroxylase deficiency.

Merke DP, Tajima T, Chhabra A, Barnes K, Mancilla E, Baron J, Cutler GB Jr. Merke DP, et al. J Clin Endocrinol Metab. 1998 Jan;83(1):270-3. doi: 10.1210/jcem.83.1.4513. J Clin Endocrinol Metab. 1998. PMID: 9435454

5

Therapeutic controversy: The role of laparoscopic surgery in adrenal disease.

Wells SA, Merke DP, Cutler GB Jr, Norton JA, Lacroix A. Wells SA, et al. Among authors: merke dp. J Clin Endocrinol Metab. 1998 Sep;83(9):3041-9. doi: 10.1210/jcem.83.9.5068-1. J Clin Endocrinol Metab. 1998. PMID: 9745398 No abstract available.

6

Hypogonadotropic hypogonadism in a female caused by an X-linked recessive mutation in the DAX1 gene.

Merke DP, Tajima T, Baron J, Cutler GB Jr. Merke DP, et al. N Engl J Med. 1999 Apr 22;340(16):1248-52. doi: 10.1056/NEJM199904223401605. N Engl J Med. 1999. PMID: 10210708 Free article. No abstract available.

7

Testicular adrenal rest tissue in congenital adrenal hyperplasia: serial sonographic and clinical findings.

Avila NA, Shawker TS, Jones JV, Cutler GB Jr, Merke DP. Avila NA, et al. Among authors: merke dp. AJR Am J Roentgenol. 1999 May;172(5):1235-8. doi: 10.2214/ajr.172.5.10227495. AJR Am J Roentgenol. 1999. PMID: 10227495

8

Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia.

Merke DP, Keil MF, Jones JV, Fields J, Hill S, Cutler GB Jr. Merke DP, et al. J Clin Endocrinol Metab. 2000 Mar;85(3):1114-20. doi: 10.1210/jcem.85.3.6462. J Clin Endocrinol Metab. 2000. PMID: 10720048 Clinical Trial.

9

Use of aromatase inhibitors in precocious puberty.

Feuillan P, Merke D, Leschek EW, Cutler GB Jr. Feuillan P, et al. Endocr Relat Cancer. 1999 Jun;6(2):303-6. doi: 10.1677/erc.0.0060303. Endocr Relat Cancer. 1999. PMID: 10731123 Review.

10

Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasia.

Merke DP, Cho D, Calis KA, Keil MF, Chrousos GP. Merke DP, et al. J Clin Endocrinol Metab. 2001 Jan;86(1):441-5. doi: 10.1210/jcem.86.1.7275. J Clin Endocrinol Metab. 2001. PMID: 11232038

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters